Market Trends of Europe Anesthesia Drugs Industry
This section covers the major market trends shaping the Europe Anesthesia Drugs Market according to our research experts:
Application in Plastic and Cosmetic Surgeries is Expected to Witness High Growth Over the Forecast Period
Plastic surgery is focused on the reconstruction and correction of facial and bodily defects, such as birth disorders, trauma, and burns. In addition, cosmetic surgery is performed to enhance a patient's appearance and improve aesthetic appeal, symmetry, and proportion of body parts. It is performed in all areas of the head, neck, and body. Cosmetic surgery includes breast enhancement, facial contouring, facial rejuvenation, body contouring, and skin rejuvenation.
The advances in plastic surgery were furthered by the progress in anesthesiology, making it the cornerstone on which surgical progress was made. The availability of new anesthetics and adjuvant drugs, advances in trans- and postoperative monitoring, and the early prevention of complications facilitated these advances.
The COVID-19 pandemic affected plastic and cosmetic surgeries across European countries, which affected the market's growth. An article titled 'Elective, Non-urgent Procedures and Anesthetic Surgery in the Wake of SARS-COVID-19: Considerations Regarding Safety, Feasibility, and Impact on Clinical Management', published in the Journal of Anesthetic Plastic Surgery in May 2020, discussed the considerations for patient selection, choice of procedural complexity, duration of the procedure, type of anesthesia, etc., for surgical/anesthesia risk management and clinical management. Hence, it is observed that anesthesia is one of the integral parts of surgical procedures and the segment will witness healthy growth over the forecast period.
Facial rejuvenation and body contouring surgeries are widely performed in European countries, which is augmenting the demand for the anesthesia drugs used in such surgeries. In the case of cosmetic surgery, local anesthesia, IV sedation, or general anesthesia is commonly used. Local anesthesia is used during the surgical removal of lumps. It is used in cases of small wound revisions. Propofol, remifentanil, dexmedetomidine, and ketamine are among the most commonly used anesthetics in cosmetic surgeries. According to the International Society of Anesthetic Plastic Surgery 2020 report, in Italy, the total number of surgical procedures focusing on the head and head was 117,300, followed by 75,108 breast surgeries and 52,992 body extremities surgeries. The rising number of plastic and cosmetic surgeries in the region is driving the growth of the anesthesia drugs market.
Hence, the aforementioned factors are expected to impact the market positively over the forecast period.
Germany is Expected to Hold Significant Share in the Europe Anesthesia Drugs Market During the Forecast Period
Germany is expected to hold a major share of the European anesthesia drugs market, owing to the increasing number of surgeries and emergency cases, rising geriatric population, rising prevalence of chronic diseases, and increasing healthcare expenditure.
According to an article titled 'Frequency of cataract surgery and its impact on visual function-results from the German Gutenberg Health Study', published in the journal of Graefe's Archive for Clinical and Experimental Ophthalmology volume in June 2020, established that the frequency of cataract surgery is low at younger ages, and it increases up to 26% at the age of 70-74 years in Germany. As anesthesia is primarily given while operating on patients, the increase in the number of surgeries is driving the market's growth positively.
As per the German Society of Anesthesiology and Intensive Care Medicine, data updated in the year 2020, there was an exponential growth in the number of specialists in anesthesiology, both in hospitals and in private study. This trend is likely to continue over the forecast period. According to the International Society of Anesthetic Plastic Surgery 2020 report, in Germany, the total number of surgical procedures focusing on the head and head was 158,137, followed by 136,718 breast surgeries and 131,000 body extremities surgeries. The rising number of plastic and cosmetic surgeries in the region is driving the growth of the anesthesia drugs market.
Market players are merging with and acquiring other companies, besides launching products associated with anesthesia drugs. For example, in August 2020, the German company, PAION AG, launched the product, Anerem (Remimazolam), for general use in anesthesia. In October 2020, Fresenius Kabi introduced an anesthetic, a D+RFID smart-labeled product, Diprivan (propofol), in a 20 ml vial. The recent developments by the market players are positively influencing the overall market in Germany.
Thus, the above-mentioned factors are expected to drive the growth of the anesthesia drugs market in Germany during the forecast period.
